This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Long‐term efficacy and safety of the interleukin‐1 inhibitors anakinra and canakinumab in refractory Behçet disease uveitis and concomitant bladder papillary carcinoma. Issue 9 (September 2017)
Record Type:
Journal Article
Title:
Long‐term efficacy and safety of the interleukin‐1 inhibitors anakinra and canakinumab in refractory Behçet disease uveitis and concomitant bladder papillary carcinoma. Issue 9 (September 2017)
Main Title:
Long‐term efficacy and safety of the interleukin‐1 inhibitors anakinra and canakinumab in refractory Behçet disease uveitis and concomitant bladder papillary carcinoma